Krystal Biotech (KRYS) Consolidated Net Income (2016 - 2026)
Krystal Biotech (KRYS) reported Consolidated Net Income of $63.05 million for Q3 2026, down 20.6% from $79.37 million a year earlier but up 15.1% from the prior quarter.
Krystal Biotech (KRYS) Consolidated Net Income (2016 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Krystal Biotech's Consolidated Net Income came in at $225.14 million, up 13.2% year-over-year; for FY2025, it was $204.83 million, up 129.7% from FY2024.
- By year, Consolidated Net Income came in at $89.16 million in FY2024 (+715.6%), $10.93 million in FY2023, -$139.98 million in FY2022 and -$69.57 million in FY2021.
- Five-year quarterly Consolidated Net Income spans a low of -$50.22 million in Q1 2022 and a high of $80.75 million in Q3 2023.
- Year over year, Consolidated Net Income gained in six of the last seven quarters, with growth averaging 122.0%.
- The high point for year-over-year Consolidated Net Income in five years was Q4 2024 (growth of 423.6%); the low point was Q3 2024 (a decline of 66.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $54.77 million (Q2 2026), $55.93 million (Q1 2026) and $51.39 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 58.17 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 58.17 Mn |
| Jun 30, 2026 | 52.06 Mn |
| Mar 31, 2026 | 53.17 Mn |
| Dec 31, 2025 | 51.44 Mn |
| Sep 30, 2025 | 79.31 Mn |
| Jun 30, 2025 | 39.10 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 43.78 Mn |
| Sep 30, 2024 | 29.33 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 9.71 Mn |
| Sep 30, 2023 | 80.60 Mn |
| Jun 30, 2023 | -33.29 Mn |
| Mar 31, 2023 | -44.72 Mn |
| Dec 31, 2022 | -31.31 Mn |
| Sep 30, 2022 | -29.78 Mn |
| Jun 30, 2022 | -28.46 Mn |
| Mar 31, 2022 | -51.00 Mn |
| Dec 31, 2021 | -21.96 Mn |
Krystal Biotech Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KRYS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();